世界卫生组织非洲区域47个国家的COVID-19:对过去趋势和未来模式的建模分析
该建模分析整合报告感染与死亡数据、文献及免疫与变异株信息,用部分观测马尔可夫决策过程和SEIRD框架估算非洲区域SARS-CoV-2感染与死亡。模型估计2020—2021年感染505.6百万例(95%CI 476.0-536.2),仅1.4%报告;死亡439 500例,35.3%报告。作者认为检测遗漏多数感染,需加强监测和血清流行率研究。
要点
- 模型估计2020—2021年非洲区域SARS-CoV-2感染505.6百万例(95%CI 476.0-536.2),仅1.4%报告。
- 估计死亡439 500例(95%CI 344 374-574 785),35.3%报告为COVID-19相关死亡。
- 截至2021年12月31日疫苗接种覆盖率14.7%,52.3%人口估计有部分SARS-CoV-2免疫力。
核心结论
- 非洲区域估计COVID-19感染数与世界其他地区相似,但死亡较少。
- 模型提示当前SARS-CoV-2检测方法遗漏大多数感染,结果与代表性血清流行率研究一致。
- 作者认为需监测住院、合并症和新变异株出现,并扩大代表性血清流行率研究作为核心应对策略。
研究设计与样本
- 对世界卫生组织非洲区域47个国家进行建模分析,整合报告感染与死亡数据、已发表文献及免疫状态和关注变异株信息。
- 模型通过部分观测马尔可夫决策过程整合,采用傅里叶级数和SEIRD框架,按国家每周运行,从各国首次报告感染至2021年12月31日,并外推至2022年底。
- 外推包括基于可能新变异株(传播性、严重性或免疫原性不同)的三种情景。
主要发现
- 2020年1月1日至2021年12月31日,模型估计非洲区域SARS-CoV-2感染505.6百万例(95%CI 476.0-536.2),仅1.4%(71例中1例)报告。
- 估计死亡439 500例(95%CI 344 374-574 785),其中35.3%(3例中1例)报告为COVID-19相关死亡。
- 2020年和2021年感染数相似,但81%的死亡发生在2021年。
- 截至2021年12月31日疫苗接种覆盖率14.7%,估计52.3%(95%CI 43.5-95.2)的区域人口有部分SARS-CoV-2免疫力。
- 到2022年底,估计感染仍高,约166.2百万例(95%CI 157.5-174.9),但死亡大幅降至22 563例(14 970-38 831)。
临床怎么用
- 作者认为需监测住院、合并症和关注变异株出现,并扩大代表性血清流行率研究作为核心应对策略。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COVID-19 has affected the African region in many ways. We aimed to generate robust information on the transmission dynamics of COVID-19 in this region since the beginning of the pandemic and throughout 2022. METHODS: For each of the 47 countries of the WHO African region, we consolidated COVID-19 data from reported infections and deaths (from WHO statistics); published literature on socioecological, biophysical, and public health interventions; and immunity status and variants of concern, to build a dynamic and comprehensive picture of COVID-19 burden. The model is consolidated through a partially observed Markov decision process, with a Fourier series to produce observed patterns over time based on the SEIRD (denoting susceptible, exposed, infected, recovered, and dead) modelling framework. The model was set up to run weekly, by country, from the date the first infection was reported in each country until Dec 31, 2021. New variants were introduced into the model based on sequenced data reported by countries. The models were then extrapolated until the end of 2022 and included three scenarios based on possible new variants with varying transmissibility, severity, or immunogenicity. FINDINGS: Between Jan 1, 2020, and Dec 31, 2021, our model estimates the number of SARS-CoV-2 infections in the African region to be 505·6 million (95% CI 476·0-536·2), inferring that only 1·4% (one in 71) of SARS-CoV-2 infections in the region were reported. Deaths are estimated at 439 500 (95% CI 344 374-574 785), with 35·3% (one in three) of these reported as COVID-19-related deaths. Although the number of infections were similar between 2020 and 2021, 81% of the deaths were in 2021. 52·3% (95% CI 43·5-95·2) of the region's population is estimated to have some SARS-CoV-2 immunity, given vaccination coverage of 14·7% as of Dec 31, 2021. By the end of 2022, we estimate that infections will remain high, at around 166·2 million (95% CI 157·5-174·9) infections, but deaths will substantially reduce to 22 563 (14 970-38 831). INTERPRETATION: The African region is estimated to have had a similar number of COVID-19 infections to that of the rest of the world, but with fewer deaths. Our model suggests that the current approach to SARS-CoV-2 testing is missing most infections. These results are consistent with findings from representative seroprevalence studies. There is, therefore, a need for surveillance of hospitalisations, comorbidities, and the emergence of new variants of concern, and scale-up of representative seroprevalence studies, as core response strategies. FUNDING: None.
引用
- Cabore JW, Karamagi HC, Kipruto HK, et al. COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns. Lancet Glob Health. 2022. PMID: 35659911. doi:10.1016/S2214-109X(22)00233-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。